Related Experiment Videos

Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis

J Philipp1, K Vo, K E Gurley

  • 1Fred Hutchinson Cancer Research Center, 1100 Fairview N., Seattle, Washington, WA 98109, USA.

Oncogene
|September 1, 1999
PubMed

Insights

The tumor suppressor p27 Kip1 (p27) accelerates tumor growth and progression, while p21 Cip1 (p21) deficiency leads to poorly differentiated, high-grade tumors. Both proteins play distinct roles in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cyclin-dependent kinase inhibitors p27 Kip1 (p27) and p21 Cip1 (p21) regulate cell proliferation.
  • p27 is recognized as a tumor suppressor gene.
  • The tumor suppressor phenotype of p21 requires further investigation.

Purpose of the Study:

  • To elucidate the mechanism of tumor suppression by p27.
  • To determine if p21 exhibits a tumor suppressor phenotype.
  • To investigate the roles of p27 and p21 in chemical carcinogenesis.

Main Methods:

  • Utilized a two-stage skin carcinogenesis model in p27 and p21 knockout mice.
  • Induced initiation with DMBA (H-ras mutation) and promotion with TPA.
  • Analyzed tumor development, growth rate, progression, differentiation, and H-ras mutation status.

Main Results:

  • p27 deficiency did not affect tumor initiation but increased papilloma growth rate and accelerated carcinoma development.
  • p27 deficiency led to faster clonal expansion of initiated cells and was partially antagonistic to Ras-driven tumor growth.
  • p21 deficiency did not significantly alter tumor number, growth, or progression but resulted in poorly differentiated, anaplastic carcinomas.

Conclusions:

  • p27 plays a crucial role in suppressing tumor promotion and progression.
  • p21 deficiency primarily impacts tumor differentiation, leading to higher-grade malignancies.
  • Both p27 and p21 exhibit distinct tumor suppressor functions in chemical carcinogenesis.

Related Concept Videos